CSF levels of tau, ptau181, Aβ42 are well-established AD endophenotypes and have allowed us to identify novel variants associated not only with tau and ptau181 levels but also with AD risk, tangle pathology, and cognitive decline [18]. Here, MAPT is linked to Alzheimer disease.